| | August 20188UTLOOK Healthcare Tech IN MY OPINIONthrough Academic DetailingBy Joy Leotsakos, Senior Clinical Pharmacist, Atrius HealthAcademic detailing, described as "university or non-commercial-based educational outreach," is crucial for enhancing patient care and reducing healthcare costs in the realm of medication therapy. With a goal of improving the prescribing of targeted drugs, academic detailing typically involves face-to-face education of prescribers by trained healthcare professionals (typically pharmacists, physicians, or nurses) who work to ensure that prescribing is consistent with medical evidence from randomized controlled trials. A key component of non-commercial or university-based detailing programs is that they (academic detailers/clinical educators, management, staff, program developers, etc.) do not have any financial links to the pharmaceutical industry. Academic detailing has been studied for over 25 years and has proven effective at improving prescribing of targeted medications about 5 percent from baseline. Though it is primarily used to affect prescribing, it is also used to educate providers regarding other non-drug interventions, such as healthcare screening guidelines.As organizations develop and refine their academic detailing programs to improve patient care, our experiences at Atrius Health have showed us that academic detailing must be a continuous process of evaluation and collaboration for adapting to changes in today's healthcare environment. Our Academic Detailing Service (ADS) for the Atrius Health Clinical Pharmacy program has evolved over the past several years through the evaluation of its impact, solicitation of internal feedback, and by working with others in the field, including the National Resource Center for Academic Detailing (NaRCAD).When we began the clinical pharmacy ADS program in 2011, our clinical pharmacists detailed clinicians in individual Keeping Pace with a Changing Healthcare EnvironmentJoy LeotsakosClinical pharmacists used our ADS workflow to provide an educational presentation on the new anticoagulants, the evidence base for their place in therapy, supporting documents and prescribing tools for appropriate use"
< Page 7 | Page 9 >